Transfer of cells into patients for medical purposes has been established as a viable treatment strategy for multiple disease areas including cancers.  OranssiBio offers a wide range of technical development and manufacturing expertise across a variety types of cells including chimeric antigen receptor T cells (CAR-T), natural killer cells (NKs), and iPSCs.

At OranssiBio, our cell platform provides following features:

  • US/EU compliant facility with GMP and other quality requirements;

  • Multiple clean rooms equipped with state-of-art automatic closed process equipment, suit for autologous and allogeneic cell productions ;

  • Fully integrated services covering process development, analytical method development, GMP manufacturing, quality control, stability study and CMC regulatory support;
  • A full suite of analytical methods for in-process controls and finish product release ensuring highest quality and safety of your product.

An Illustrated Flowchart for Cell

  • US/EU compliant facility with GMP and other quality requirements;

  • Multiple clean rooms equipped with state-of-art automatic closed process equipment, suit for autologous and allogeneic cell productions ;

  • Fully integrated services covering process development, analytical method development, GMP manufacturing, quality control, stability study and CMC regulatory support;
  • A full suite of analytical methods for in-process controls and finish product release ensuring highest quality and safety of your product.